Capsules, injections or nasal spray: which form the research used for each peptide, and what buyers say
The short answer
Most peptides were studied as injections, and the form on sale does not always match. Semax and Selank were researched mainly through the nose; CJC-1295, tesamorelin and retatrutide as injections under the skin. Oral BPC-157 rests on rat drinking-water studies, and typical oral absorption of peptide drugs is under 1%.
Short answer: the format a peptide is sold in and the format it was studied in are often two different things. Most of the peptides people buy online were researched as injections, a few were researched almost entirely as nasal drops or sprays, and the oral capsules sold for some of them rest on very little. This page goes substance by substance: the route the research used, the forms the peptide is sold in, how strong the evidence is in plain words, what absorption science says about swallowing or spraying a peptide, and what buyers say about each format.
Which form did the research actually use for each peptide?
For most of these substances the key studies used injections, either in animals or in small human trials; Semax and Selank are the main exceptions, studied largely through the nose. The table puts one substance on each row. The “sold as” column lists the forms on Bodybuilding Peptides’ product pages as captured on October 12, 2026, because that is one storefront whose formats we checked; other sellers differ.
| Substance | Route used in the key studies | Sold at Bodybuilding Peptides as | Evidence level, in words |
|---|---|---|---|
| BPC-157 | Rats: injection into the abdomen, drinking water and a cream all used in one ligament study (Cerovecki et al., 2010). People: three pilots, by knee injection, for bladder pain, and intravenous (McGuire et al., 2025) | Injectable vial; oral capsule; oral capsule with TB-500; two injectable blends | Mostly animal studies; three small human pilots, none of them oral |
| TB-500 | TB-500 itself, described as synthetic thymosin beta-4: rat abdominal injections (Biçer et al., 2026). Thymosin beta-4 in people: intravenous in healthy volunteers (Ruff et al., 2010) and eye drops for dry eye (Sosne and Ousler, 2015) | Injectable vial; oral capsule with BPC-157; two injectable blends | Animal studies of TB-500; small human trials of thymosin beta-4 only by other routes |
| Semax | Nasal in people (Lebedeva et al., 2018); nasal and abdominal injection compared in rats (Manchenko et al., 2010) | Nasal spray; injectable vial combined with Selank | Small human studies, mostly Russian, by the nasal route |
| Selank | Russian anxiety trial indexed in PubMed under intranasal administration (Zozulia et al., 2008); rat tracer study of four routes (Ashmarin et al., 2008) | Nasal spray; injectable vial combined with Semax | Small human trials, mostly Russian, plus animal studies |
| CJC-1295 | Injection under the skin in healthy adults (Teichman et al., 2006) | Injectable blend with ipamorelin | Small human trials measuring hormone levels, not outcomes |
| Ipamorelin | Intravenous infusion in hospital patients after bowel surgery (Beck et al., 2014) | Injectable blends with CJC-1295 or tesamorelin | One mid-sized human trial, by intravenous infusion, with no significant benefit |
| Tesamorelin | Injection under the skin, once daily, on the approved label (Egrifta WR label) | Injectable vial; injectable blend with ipamorelin | Approved drug, labeled use; other uses are off-label |
| MOTS-c | Mice: abdominal injections (Lee et al., 2015) | Injectable vial | Mostly mouse studies |
| Epitalon | Mice: injections under the skin (Anisimov et al., 2003); human cells in a dish (Khavinson et al., 2003) | Injectable vial | Cell and animal studies |
| Thymosin alpha-1 | Usually injected under the skin twice a week, per a literature review (Dominari et al., 2020) | Injectable vial | Human clinical studies, summarized in reviews |
| GHK-Cu | Creams and serums on the skin in small human studies (Pickart and Margolina, 2018) | Only inside an injectable blend with BPC-157 and TB-500 | Small topical human studies; the review we checked describes no injected human study |
| 5-Amino-1MQ | Mice: injections under the skin (Neelakantan et al., 2018) | Oral tablet | Mouse studies; a small molecule, not a peptide |
| Retatrutide | Injection under the skin, once weekly, in a 338-person phase 2 trial (Jastreboff et al., 2023) | Injectable vial | Human phase 2 trial; investigational |
| Melanotan II | Injection under the skin in a pilot study of three men (Dorr et al., 1996) | Form not stated on the product page | A tiny early human pilot |
Three patterns stand out. Oral forms on sale (BPC-157 capsules, the BPC-157 and TB-500 capsule, 5-Amino-1MQ tablets) were not the forms the cited research tested in people or animals. Nasal sprays match the research best for Semax and Selank. And several substances with human data, such as tesamorelin, retatrutide and CJC-1295, were studied as injections under the skin, which is also how they are sold.
Do oral peptides work?
Usually very little of a swallowed peptide reaches the blood, so an oral peptide has to clear a high bar before it can work. A 2025 review in Pharmaceutics reports that peptide and protein drugs have typical oral bioavailability levels of under 1%, and sometimes under 0.1%, because stomach acid, digestive enzymes and the gut lining all work against them. The review’s main example, the approved tablet form of semaglutide, still absorbs at about 1%; the review says its high potency keeps it clinically effective, and the tablet is formulated with an absorption enhancer called SNAC.
BPC-157 is the oral case people raise most. In rats it was effective when given in drinking water, alongside injection and a cream, in the same ligament-healing study. That is a real animal finding, but a 2025 review found only three human pilot studies of BPC-157, and none used a capsule: they covered knee injections, a bladder condition (interstitial cystitis) and intravenous safety testing (McGuire et al., 2025). Our sister site covers that comparison in depth in BPC-157 capsules vs injection.
5-Amino-1MQ is a different case. It is a small molecule rather than a peptide, so the peptide absorption figures above do not map onto it directly. But the mouse study that drew attention to it gave it by injection under the skin, not by mouth, so the tablet format is not the one that research tested either.
Why are Semax and Selank sold as nasal sprays?
Because the nose is the route their research leaned on, not because a spray is an efficient way to deliver a peptide. In people, the Semax brain-imaging study gave it intranasally to 14 healthy volunteers, against 10 on placebo, and a Russian anxiety trial in 62 patients, which compared Selank with the benzodiazepine medazepam rather than a placebo, is indexed in PubMed under intranasal administration (Zozulia et al., 2008). In rats, a tracer study of Selank given four ways (into the abdomen, the nose, the stomach and a vein) concluded the nasal route was optimal for delivery to the central nervous system.
The absorption numbers are still small. A review of nasal delivery notes that the nasal bioavailability of hydrophilic peptides and proteins is usually less than 1%, and that absorption falls as molecules get larger. In rats, 2 minutes after a nasal dose of labeled Semax, about 0.093% of the dose’s radioactive label per gram was found in the brain, and the peptide broke down quickly. The sister-site guides on Semax nasal spray vs injection and Selank nasal spray cover both peptides in detail.
Is an injection always the stronger form?
No. An injection puts more peptide into the bloodstream, but that is not the same as more effect where it matters. In a rat study comparing routes, Semax given through the nose was more potent for learning than Semax injected into the abdomen, while only the injected form changed pain sensitivity. The authors read that as the two routes engaging different brain mechanisms, which is a long way from “injection is the upgrade.”
For other substances the injection really is the studied form. CJC-1295 raised growth hormone and IGF-1 for days after a single injection under the skin in healthy adults, and retatrutide’s phase 2 trial used a once-weekly injection under the skin. Even then, the studied route is not always the one sold. Ipamorelin’s only sizable human trial used intravenous infusions in hospital patients after bowel surgery and found no significant difference from placebo on its main measure. The human trials of thymosin beta-4, the protein behind the TB-500 name, used an intravenous infusion and eye drops, not home injections.
What side effects come with each format?
The format changes which risks you take on, but for most of these peptides the human safety data are too thin to rank formats with confidence. What the sources do show:
- Injections add injection-site reactions and a sterility question. For thymalfasin, the drug form of thymosin alpha-1, a review lists local irritation, redness or discomfort at the injection site as the most common adverse effects. An injected product that is not sterile skips the body’s first line of defense, which is why buyer-side quality checks matter more for vials.
- Nasal sprays avoid needles. Semax users in our community data debate which liquid to dilute it in, and some mention nasal irritation.
- Oral capsules and tablets avoid needles too, but for a peptide the main issue is whether anything is absorbed at all, per the absorption review above.
- The molecule itself carries its own effects in any form. In the Melanotan II pilot, side effects included nausea, fatigue and spontaneous erections alongside tanning.
Format does not fix the product-quality problem either. A Belgian lab that analyzed seized Semax and Selank preparations noted these peptides are freely sold online as powder for injection or in nasal sprays, and that, to the authors’ knowledge, neither had completed clinical trials.
What about blends and combination products?
A blend combines peptides in one vial or capsule; it is a product decision, not a delivery method, and blends are rarely what the research tested. In a 2026 rat Achilles-tendon study, TB-500 improved several healing measures and BPC-157 showed smaller gains that mostly missed statistical significance, but the combination did not confer additional benefits compared to either agent alone. Semax and Selank were each studied on their own, mostly through the nose, while the combined Semax and Selank product at the storefront we checked is an injectable vial. Our buying guide explains why blends are also the hardest format for a buyer to verify.
Does a capsule or spray cost less than an injection?
Sometimes on the price tag, but the price per unit says nothing about how much reaches your bloodstream. If a capsule delivers a small fraction of what an injection does, as the absorption research suggests for most peptides, a lower sticker price does not mean a lower cost for the amount that is actually absorbed, and we found no published measurement of that for the oral peptide products on sale. For dated listing prices across formats and plans, the hub keeps a peptide cost explainer.
What do buyers say about each format?
Buyers argue about format mostly in terms of convenience, absorption and trust in the product, and their claims are anecdotes, not measurements. Our Community Insights summaries, built from public posts on X in mid-July 2026, show a few recurring threads:
- Oral Epitalon. In our Epitalon summary of 16 posts, some users debate whether oral forms work given that oral bioavailability is described as generally poor; some claim effects anyway, and one poster who uses oral forms disclosed being an affiliate. See the Epitalon community page.
- Oral BPC-157 for the gut. In our network-wide BPC-157 summary, several users describe taking it by mouth for gut repair and what they call leaky gut.
- Nasal Semax and Selank. Semax posters debate which diluent to use for nasal use, some noting irritation; Selank posters describe nasal blends mixed with other peptides and additives such as eucalyptus. See the Semax and Selank pages.
- Fewer injections. In CJC-1295 threads, some favor the DAC version because they see it as a longer-lasting, less frequent injection. See the CJC-1295 community page.
- Blends. Some TB-500 buyers say they stopped buying pre-mixed stack vials, arguing blends are where mislabeling happens. See the TB-500 community page.
Status: Of the substances above, tesamorelin is FDA-approved only as Egrifta, for HIV-related abdominal fat (other uses are off-label), and retatrutide is investigational; the rest are not FDA-approved, and several are sold by some telehealth providers as a compounded prescription. What these status terms mean.
The honest bottom line
Ask which form the research used before asking which form is most convenient. For Semax and Selank, the spray is the studied route. For tesamorelin, retatrutide and CJC-1295, it is an injection under the skin. For oral BPC-157, the BPC-157 and TB-500 capsule and 5-Amino-1MQ tablets, the format on sale is not the one the cited research tested, and for peptides in general very little of a swallowed or sprayed dose is absorbed. None of that tells you whether a given product contains what its label says; our buying guide covers how to check that part.
Educational information only, not medical advice, and not a guide to dosing. Research statements are sourced to the studies and the FDA label linked above; community statements summarize our Community Insights data and are anecdotal; product formats are as listed by one storefront on October 12, 2026. Updated October 12, 2026.
Sources (24)
Advertising disclosure: links marked "Paid link" go to Bodybuilding Peptides (trybbpeptides.com), an affiliate destination, and Peptides in Review may earn a commission if you buy there. Our coverage is independent of that relationship, and nothing on this page is medical or legal advice.